CD4 T cells have been implicated in cancer immunity for their helper functions. Moreover, their direct cytotoxic potential has been shown in some patients with cancer. Here, by mining single-cell RNA-seq datasets, we identified CD4 T cell clusters displaying cytotoxic phenotypes in different human cancers, resembling CD8 T cell profiles. Using the peptide-MHCII-multimer technology, we confirmed ex vivo the presence of cytolytic tumor-specific CD4 T cells. We performed an integrated phenotypic and functional characterization of these cells, down to the single-cell level, through a high-throughput nanobiochip consisting of massive arrays of picowells and machine learning. We demonstrated a direct, contact-, and granzyme-dependent cytotoxic activity against tumors, with delayed kinetics compared to classical cytotoxic lymphocytes. Last, we found that this cytotoxic activity was in part dependent on SLAMF7. Agonistic engagement of SLAMF7 enhanced cytotoxicity of tumor-specific CD4 T cells, suggesting that targeting these cells might prove synergistic with other cancer immunotherapies.

Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer / Cachot, A.; Bilous, M.; Liu, Y. -C.; Li, X.; Saillard, M.; Cenerenti, M.; Rockinger, G. A.; Wyss, T.; Guillaume, P.; Schmidt, J.; Genolet, R.; Ercolano, G.; Protti, M. P.; Reith, W.; Ioannidou, K.; de Leval, L.; Trapani, J. A.; Coukos, G.; Harari, A.; Speiser, D. E.; Mathis, A.; Gfeller, D.; Altug, H.; Romero, P.; Jandus, C.. - In: SCIENCE ADVANCES. - ISSN 2375-2548. - 7:9(2021). [10.1126/sciadv.abe3348]

Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer

Ercolano G.
Membro del Collaboration Group
;
2021

Abstract

CD4 T cells have been implicated in cancer immunity for their helper functions. Moreover, their direct cytotoxic potential has been shown in some patients with cancer. Here, by mining single-cell RNA-seq datasets, we identified CD4 T cell clusters displaying cytotoxic phenotypes in different human cancers, resembling CD8 T cell profiles. Using the peptide-MHCII-multimer technology, we confirmed ex vivo the presence of cytolytic tumor-specific CD4 T cells. We performed an integrated phenotypic and functional characterization of these cells, down to the single-cell level, through a high-throughput nanobiochip consisting of massive arrays of picowells and machine learning. We demonstrated a direct, contact-, and granzyme-dependent cytotoxic activity against tumors, with delayed kinetics compared to classical cytotoxic lymphocytes. Last, we found that this cytotoxic activity was in part dependent on SLAMF7. Agonistic engagement of SLAMF7 enhanced cytotoxicity of tumor-specific CD4 T cells, suggesting that targeting these cells might prove synergistic with other cancer immunotherapies.
2021
Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer / Cachot, A.; Bilous, M.; Liu, Y. -C.; Li, X.; Saillard, M.; Cenerenti, M.; Rockinger, G. A.; Wyss, T.; Guillaume, P.; Schmidt, J.; Genolet, R.; Ercolano, G.; Protti, M. P.; Reith, W.; Ioannidou, K.; de Leval, L.; Trapani, J. A.; Coukos, G.; Harari, A.; Speiser, D. E.; Mathis, A.; Gfeller, D.; Altug, H.; Romero, P.; Jandus, C.. - In: SCIENCE ADVANCES. - ISSN 2375-2548. - 7:9(2021). [10.1126/sciadv.abe3348]
File in questo prodotto:
File Dimensione Formato  
20) Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer.pdf

solo utenti autorizzati

Tipologia: Versione Editoriale (PDF)
Licenza: Accesso privato/ristretto
Dimensione 6.33 MB
Formato Adobe PDF
6.33 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/876819
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 144
  • ???jsp.display-item.citation.isi??? 140
social impact